Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Robust homology-directed repair within mouse mammary tissue is not specifically affected by Brca2 mutation
    Journal Article

    Kass, E. M.; Lim, P. X.; Helgadottir, H. R.; Moynahan, M. E.; Jasin, M.
    Nature Communications (2016)

    Fulltext@MSK | Save
  • Ionic immune suppression within the tumour microenvironment limits T cell effector function
    Journal Article

    Eil, R.; Vodnala, S. K.; Clever, D.; Klebanoff, C. A.; Sukumar, M.; Pan, J. H.; Palmer, D. C.; Gros, A.; Yamamoto, T. N.; Patel, S. J.; more...
    Nature (2016)

    Fulltext@MSK | Save
  • Initial results of a prospective clinical trial of (18)F-fluciclovine PET/CT in newly diagnosed invasive ductal and invasive lobular breast cancers
    Journal Article

    Ulaner, G. A.; Goldman, D. A.; Gönen, M.; Pham, H.; Castillo, R.; Lyashchenko, S. K.; Lewis, J. S.; Dang, C.
    Journal of Nuclear Medicine (2016)

    Fulltext@MSK | Save
  • Detection of HER2-positive metastases in patients with HER2-negative primary breast cancer using 89Zr-trastuzumab PET/CT
    Journal Article

    Ulaner, G. A.; Hyman, D. M.; Ross, D. S.; Corben, A.; Chandarlapaty, S.; Goldfarb, S.; McArthur, H.; Erinjeri, J. P.; Solomon, S. B.; Kolb, H.; more...
    Journal of Nuclear Medicine (2016)

    Fulltext@MSK | Save
  • Customizing functionality and payload delivery for receptor-engineered T cells
    Journal Article

    Klebanoff, C. A.; Restifo, N. P.
    Cell (2016)

    Fulltext@MSK | Save
  • Exercise and prognosis on the basis of clinicopathologic and molecular features in early-stage breast cancer: The LACE and pathways studies
    Journal Article

    Jones, L. W.; Kwan, M. L.; Weltzien, E.; Chandarlapaty, S.; Sternfeld, B.; Sweeney, C.; Bernard, P. S.; Castillo, A.; Habel, L. A.; Kroenke, C. H.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save
  • PDK1-SGK1 signaling sustains AKT-independent mTORC1 activation and confers resistance to PI3Kα inhibition
    Journal Article

    Castel, P.; Ellis, H.; Bago, R.; Toska, E.; Razavi, P.; Carmona, F. J.; Kannan, S.; Verma, C. S.; Dickler, M.; Chandarlapaty, S.; more...
    Cancer Cell (2016)

    Fulltext@MSK | Save
  • Updating the American Society of Clinical Oncology Value Framework: Revisions and reflections in response to comments received
    Journal Article

    Schnipper, L. E.; Davidson, N. E.; Wollins, D. S.; Blayney, D. W.; Dicker, A. P.; Ganz, P. A.; Hoverman, J. R.; Langdon, R.; Lyman, G. H.; Meropol, N. J.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase III trial evaluating letrozole as first-line endocrine therapy with or without bevacizumab for the treatment of postmenopausal women with hormone receptor-positive advanced-stage breast cancer: CALGB 40503 (Alliance)
    Journal Article

    Dickler, M. N.; Barry, W. T.; Cirrincione, C. T.; Ellis, M. J.; Moynahan, M. E.; Innocenti, F.; Hurria, A.; Rugo, H. S.; Lake, D. E.; Hahn, O.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: Prevalence, risk factors, and fall risk
    Journal Article

    Bao, T.; Basal, C.; Seluzicki, C.; Li, S. Q.; Seidman, A. D.; Mao, J. J.
    Breast Cancer Research and Treatment (2016)

    Fulltext@MSK | Save